Quantbot Technologies LP Takes $4.23 Million Position in Waters Corporation $WAT

Quantbot Technologies LP acquired a new position in shares of Waters Corporation (NYSE:WAT) in the third quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 14,092 shares of the medical instruments supplier’s stock, valued at approximately $4,225,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Brighton Jones LLC raised its stake in shares of Waters by 112.9% in the 4th quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier’s stock valued at $471,000 after acquiring an additional 673 shares during the period. Integrated Wealth Concepts LLC boosted its position in shares of Waters by 2.9% during the 1st quarter. Integrated Wealth Concepts LLC now owns 1,048 shares of the medical instruments supplier’s stock worth $386,000 after purchasing an additional 30 shares during the period. Goldman Sachs Group Inc. increased its holdings in Waters by 3.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 200,051 shares of the medical instruments supplier’s stock valued at $73,733,000 after purchasing an additional 6,976 shares during the last quarter. Empowered Funds LLC increased its holdings in Waters by 16.6% in the 1st quarter. Empowered Funds LLC now owns 1,126 shares of the medical instruments supplier’s stock valued at $415,000 after purchasing an additional 160 shares during the last quarter. Finally, Sivia Capital Partners LLC purchased a new stake in Waters in the second quarter valued at approximately $232,000. 94.01% of the stock is currently owned by hedge funds and other institutional investors.

Waters Stock Performance

NYSE WAT opened at $318.99 on Monday. The company has a market capitalization of $31.29 billion, a PE ratio of 29.62, a P/E/G ratio of 2.20 and a beta of 1.20. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.73 and a quick ratio of 1.27. Waters Corporation has a 1 year low of $275.05 and a 1 year high of $414.15. The company has a fifty day moving average of $368.77 and a two-hundred day moving average of $351.02.

Waters (NYSE:WAT) last released its quarterly earnings results on Monday, February 9th. The medical instruments supplier reported $4.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.50 by $0.03. Waters had a return on equity of 34.79% and a net margin of 20.30%.The firm had revenue of $932.36 million for the quarter, compared to analyst estimates of $928.17 million. During the same quarter last year, the company posted $4.10 earnings per share. The business’s revenue was up 6.9% on a year-over-year basis. Waters has set its FY 2026 guidance at 14.300-14.500 EPS and its Q1 2026 guidance at 2.250-2.350 EPS. As a group, analysts expect that Waters Corporation will post 12.86 earnings per share for the current year.

Analysts Set New Price Targets

Several research analysts have recently commented on the company. TD Cowen restated a “hold” rating on shares of Waters in a research report on Wednesday, November 5th. Wolfe Research raised Waters from a “peer perform” rating to an “outperform” rating and set a $480.00 target price on the stock in a research note on Wednesday, December 10th. UBS Group lowered their target price on Waters from $395.00 to $370.00 and set a “neutral” rating for the company in a report on Tuesday, February 10th. Wall Street Zen lowered shares of Waters from a “buy” rating to a “hold” rating in a research note on Sunday, February 8th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Waters in a research report on Wednesday, January 21st. Two analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $393.84.

About Waters

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.